Literature DB >> 31666328

Quantifying the impact of treatment history on plasmid-mediated resistance evolution in human gut microbiota.

Burcu Tepekule1, Pia Abel Zur Wiesch2,3, Roger D Kouyos4,5, Sebastian Bonhoeffer6.   

Abstract

To understand how antibiotic use affects the risk of a resistant infection, we present a computational model of the population dynamics of gut microbiota including antibiotic resistance-conferring plasmids. We then describe how this model is parameterized based on published microbiota data. Finally, we investigate how treatment history affects the prevalence of resistance among opportunistic enterobacterial pathogens. We simulate treatment histories and identify which properties of prior antibiotic exposure are most influential in determining the prevalence of resistance. We find that resistance prevalence can be predicted by 3 properties, namely the total days of drug exposure, the duration of the drug-free period after last treatment, and the center of mass of the treatment pattern. Overall this work provides a framework for capturing the role of the microbiome in the selection of antibiotic resistance and highlights the role of treatment history for the prevalence of resistance.

Entities:  

Keywords:  gut microbiota; plasmid-mediated resistance; prior treatment; risk factor

Mesh:

Substances:

Year:  2019        PMID: 31666328      PMCID: PMC6859334          DOI: 10.1073/pnas.1912188116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  106 in total

1.  Plasmid-mediated horizontal gene transfer is a coevolutionary process.

Authors:  Ellie Harrison; Michael A Brockhurst
Journal:  Trends Microbiol       Date:  2012-05-05       Impact factor: 17.079

2.  Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.

Authors:  T Guillard; E Cambau; F Chau; L Massias; C de Champs; B Fantin
Journal:  Antimicrob Agents Chemother       Date:  2013-09-09       Impact factor: 5.191

Review 3.  Bacteroides of the human lower intestinal tract.

Authors:  A A Salyers
Journal:  Annu Rev Microbiol       Date:  1984       Impact factor: 15.500

4.  Plasmid-mediated quinolone resistance genes, aac(6')-Ib-cr, qnrS, qnrB, and qnrA, in urinary isolates of Escherichia coli and Klebsiella pneumoniae at a teaching hospital, Thailand.

Authors:  Woravit Pasom; Aroonwadee Chanawong; Aroonlug Lulitanond; Chotechana Wilailuckana; Suthida Kenprom; Pirom Puang-Ngern
Journal:  Jpn J Infect Dis       Date:  2013       Impact factor: 1.362

5.  Risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase-producing Enterobacteriaceae.

Authors:  Yoon Soo Park; Sunmi Yoo; Mi-Ran Seo; Jin Yong Kim; Yong Kyun Cho; Hyunjoo Pai
Journal:  Int J Antimicrob Agents       Date:  2009-03-17       Impact factor: 5.283

6.  Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.

Authors:  Bin Du; Yun Long; Hongzhong Liu; Dechang Chen; Dawei Liu; Yingchun Xu; Xiuli Xie
Journal:  Intensive Care Med       Date:  2002-10-17       Impact factor: 17.440

7.  Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.

Authors:  Nicolas Allou; Emmanuelle Cambau; Laurent Massias; Françoise Chau; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

8.  Antibiotic Selection Pressure Determination through Sequence-Based Metagenomics.

Authors:  Matthias Willmann; Mohamed El-Hadidi; Daniel H Huson; Monika Schütz; Christopher Weidenmaier; Ingo B Autenrieth; Silke Peter
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

9.  Structure, function and diversity of the healthy human microbiome.

Authors: 
Journal:  Nature       Date:  2012-06-13       Impact factor: 49.962

10.  Survival and Evolution of a Large Multidrug Resistance Plasmid in New Clinical Bacterial Hosts.

Authors:  Andreas Porse; Kristian Schønning; Christian Munck; Morten O A Sommer
Journal:  Mol Biol Evol       Date:  2016-08-08       Impact factor: 16.240

View more
  5 in total

1.  Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control.

Authors:  Laura Temime; Lulla Opatowski; David Rm Smith
Journal:  Elife       Date:  2021-09-14       Impact factor: 8.140

2.  A plasmid network from the gut microbiome of semi-isolated human groups reveals unique and shared metabolic and virulence traits.

Authors:  Liliane Costa Conteville; Ana Carolina Paulo Vicente
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

3.  Characterizing Plasmids in Bacteria Species Relevant to Urinary Health.

Authors:  Cesar Montelongo Hernandez; Catherine Putonti; Alan J Wolfe
Journal:  Microbiol Spectr       Date:  2021-12-22

Review 4.  Models for Gut-Mediated Horizontal Gene Transfer by Bacterial Plasmid Conjugation.

Authors:  Logan C Ott; Melha Mellata
Journal:  Front Microbiol       Date:  2022-06-30       Impact factor: 6.064

5.  Profiling the plasmid conjugation potential of urinary Escherichia coli.

Authors:  Cesar Montelongo Hernandez; Catherine Putonti; Alan J Wolfe
Journal:  Microb Genom       Date:  2022-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.